Bruce Hollis to Surveys and Questionnaires
This is a "connection" page, showing publications Bruce Hollis has written about Surveys and Questionnaires.
Connection Strength
0.538
-
Laboratory reporting of 25-hydroxyvitamin D results: potential for clinical misinterpretation. Clin Chem. 2006 Nov; 52(11):2124-5.
Score: 0.154
-
Validation of a Vitamin D Specific Questionnaire to Determine Vitamin D Status in Athletes. Nutrients. 2019 Nov 11; 11(11).
Score: 0.095
-
Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May; 24(3):447-53.
Score: 0.060
-
A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol. 2013 Feb; 208(2):137.e1-13.
Score: 0.058
-
Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr. 2009 Dec; 28(6):678-86.
Score: 0.048
-
High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006; 1(2):59-70.
Score: 0.036
-
Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One. 2011; 6(12):e28520.
Score: 0.014
-
Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr. 2011 Aug; 106(3):339-44.
Score: 0.013
-
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res. 2011 May 11; 13(3):R50.
Score: 0.013
-
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 09; 168(11):1174-80.
Score: 0.011
-
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007 Apr; 16(4):783-8.
Score: 0.010
-
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 05; 98(7):451-9.
Score: 0.009
-
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):546-52.
Score: 0.008
-
Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology. 1998 Sep; 9(5):535-9.
Score: 0.005
-
Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc. 1995 Nov; 43(11):1269-71.
Score: 0.004